US 8846057
Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region
granted A61KA61K2039/522A61K2039/5254
Quick answer
US patent 8846057 (Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of Agriculture
- Grant date
- Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/522, A61K2039/5254, A61K2039/552, A61K39/12